Safety and efficacy of autologous hematopoietic stem‐cell transplantation following natalizumab discontinuation in aggressive multiple sclerosis
暂无分享,去创建一个
L. Massacesi | R. Saccardi | A. Mariottini | C. Innocenti | A. Repice | C. Mechi | A. Barilaro | B. Forci | E. Magnani | A. Fani | R. Nistri